Spermidine / Risk Cancer Research Results

Sper, Spermidine: Click to Expand ⟱
Features:
Spermidine : Polyamine (natural small molecule)
Sources: Found in foods like wheat germ, soybeans, mushrooms, aged cheese, and fermented foods. Typical dietary intake is ~5–20 mg/day.Top food sources = wheat germ > soybeans > aged cheddar > mushrooms > rice bran/legumes.

Ripening / fermentation: especially in aged or fermented foods like cheese, where spermidine and other polyamines can rise during ripening because microbial activity and protein breakdown contribute to amine formation. That is one reason aged cheeses can rank unusually high.
Cooking: boiling and grilling significantly reduced polyamine content in many foods, whereas microwave and sous-vide tended to preserve more.

Primary Actions: Autophagy induction, mild ROS modulation, epigenetic regulation, and modulation of polyamine metabolism.
Pathway	                Effect of Spermidine
Autophagy (ATG genes)	↑ Induction, Beclin-1 activation
mTORC1 signaling	↓ Inhibition, promotes catabolic metabolism
p53/p21	                Modulation via epigenetic changes
Polyamine metabolism	Supports or stresses proliferating cells
ROS / redox balance	Mild modulation; sensitizes cancer cells to ROS stress
Context-dependent risk: High spermidine levels might support tumor growth in polyamine-addicted cancers; dose, timing, and tumor type matter.

Chemo interaction: Generally compatible; not expected to block ROS-dependent therapy at oral doses.

Spermidine, a biogenic polyamine that declines along with aging, shows promise in restoring antitumor immunity by enhancing mitochondrial fatty acid oxidation (FAO)

Spermidine — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Autophagy induction (ATG program) ↑ autophagy → metabolic stress, growth restraint ↑ autophagy → cytoprotection, homeostasis Driver Autophagy-first mechanism Spermidine robustly induces autophagy independent of mTOR inhibition; cancer cells are more vulnerable to enforced catabolism
2 Epigenetic regulation (histone acetylation) ↓ histone acetylation (via HAT inhibition) ↓ acetylation (adaptive) Driver Chromatin-mediated transcriptional reprogramming Spermidine inhibits histone acetyltransferase activity, promoting a pro-autophagic, anti-proliferative transcriptional state
3 Polyamine metabolism / homeostasis Disrupted polyamine balance Homeostatic buffering Driver Metabolic vulnerability Cancer cells are highly dependent on polyamine flux; spermidine perturbs this balance
4 AMPK / mTOR nutrient-sensing axis ↑ AMPK; ↓ mTOR signaling ↑ AMPK (adaptive) Secondary Catabolic pressure Energy-sensing pathways reinforce autophagy and growth suppression
5 Mitochondrial function / bioenergetics ↓ metabolic flexibility ↑ mitochondrial efficiency Secondary Energy stress vs optimization Autophagy-driven mitochondrial turnover stresses tumor bioenergetics while benefiting normal cells
6 Reactive oxygen species (ROS) ↑ ROS (secondary, stress-linked) ↓ ROS Secondary Metabolism-linked redox shift ROS changes arise indirectly from autophagy and mitochondrial remodeling, not direct redox chemistry
7 NRF2 antioxidant response ↑ NRF2 (adaptive, secondary) ↑ NRF2 (protective) Adaptive Redox homeostasis reinforcement NRF2 activation reflects compensatory antioxidant signaling rather than a cytotoxic mechanism
8 Cell cycle / proliferation ↓ proliferation / ↑ arrest ↔ spared Phenotypic Cytostatic growth limitation Growth inhibition reflects sustained autophagy and epigenetic effects
9 Apoptosis sensitivity ↑ sensitivity to apoptosis (context-dependent) ↓ apoptosis Phenotypic Threshold-dependent cell death Apoptosis occurs when catabolic stress exceeds adaptive capacity


Risk, Risk: Click to Expand ⟱
Source:
Type:
Risk: by definition reduces risk of disease or cancer.
Down Target direction of risk indicates lower cancer risk.
ChemoPreventive also mean lower cancer risk. But for Chemopreventive an up arrow indicates more preventive.
Cancer Risk Impact Score (CRIS)
CRIS scale:
–5 = very strong risk reduction
–4 = strong risk reduction
–3 = moderate risk reduction
–2 = modest risk reduction
–1 = weak / context-dependent
0 = neutral

CRIS Exposure / Compound Evidence Cancers Notes
-5 Exercise (overall) VStrong Hum BC, CRC, Endo, PCa, Liv
-5 Aerobic + resistance VStrong Hum Broad inc + mort
-4 Aerobic exercise (mod–vig) VStrong Hum BC, CRC, Endo
-4 Resistance training (alone) Strong Hum BC, CRC
-3 High-intensity interval training Mod–Strong Hum BC, CRC
-2 NEAT / low-intensity activity Moderate Hum CRC
-5 Cruciferous vegetable pattern Strong Hum Lung, CRC, BC, PCa
-5 Sunlight exposure (physiologic) Strong Hum CRC, BC, PCa
-4 Fasting (metabolic pattern) Strong Mech + Hum BC, CRC, PCa
-4 Curcumin Hum + Pre GI, BC, PCa
-4 Sulforaphane Hum + Pre Lung, CRC, BC
-4 PEITC Hum + Pre Lung, CRC, PCa
-4 EGCG (tea matrix) Strong Hum GI, PCa, BC
-4 Lycopene Strong Hum PCa
-4 Apigenin Pre + Diet Hum BC, PCa, CRC
-4 Luteolin Pre + Diet Hum Lung, CRC, BC
-4 Kaempferol Diet Hum Ov, Panc, Lung
-4 Fisetin Pre + Early Hum CRC, PCa, Mel
-4 Ellagic acid → Urolithin A Hum (microbiome) CRC, PCa, BC
-3 Omega-3 (EPA/DHA) Strong Hum CRC, BC
-3 Vitamin D3 (supp) Obs + RCT CRC, BC
-3 Garlic (allicin) Mod Hum GI
-3 Mushroom beta-glucans Hum adjunct GI, BC
-3 Melatonin Hum + Mech BC, PCa
-3 Coffee (whole) Strong Hum Liv, Endo
-2 Quercetin Limited Hum Lung, CRC
-2 Resveratrol Limited Hum CRC, BC
-2 I3C / DIM Mod Hum BC, Cerv
-2 Thymoquinone Early Hum BC, CRC
-2 Beta-carotene (food) Hum Lung
-1 Vitamin K2 (MK-4/7) Limited Hum Liv, PCa
-1 Boron Obs PCa, Lung
0 Vitamin C (oral) Strong Hum
0 Genistein (soy) Strong Hum BC, PCa
0 Selenium (diet) Mixed Hum PCa
0 Capsaicin Mixed Gastric
+2 Vitamin E (alpha only) Strong RCT PCa
+2 Green tea extract (high-dose) Case reports Liv
+4 Beta-carotene (supplement) Strong RCT Lung (smokers)
+5 Alcohol (ethanol) Strong Hum BC, Liv, Eso
Evidence Hum human data VStrong very strong Strong strong Mod moderate Obs observational Pre preclinical RCT randomized controlled trial Mech mechanistic Adjunct adjunct clinical use


Scientific Papers found: Click to Expand⟱
5802- Sper,    Spermidine reduces cancer-related mortality in humans
- Review, Var, NA
EP300↓, Risk↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Proliferation, Differentiation & Cell State

EP300↓, 1,  

Functional Outcomes

Risk↓, 1,  
Total Targets: 2

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Risk, Risk
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:386  Target#:785  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page